Healthcare Analytical Testing Services Market Trends

Skyquest Technology's expert advisors have carried out comprehensive research on the healthcare analytical testing services market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.

Healthcare Analytical Testing Services Market Dynamics

Drivers

Increasing Demand for Medical Testing Services

  • The increasing demand for medical testing services drives the market growth. Due to growing aging population and the higher prevalence of chronic conditions, the demand for diagnostic testing and its associated analytical services increased manifold. This has been driven by personalized medicine because it depends heavily on advanced testing and analysis. Increasing investment by health professionals and biopharmaceuticals in analytical testing services has given a lot of momentum to the market. As accurate and reliable diagnostic outcomes have become crucial, further expansion in the use of healthcare testing services is predicted to continue.

Technological Advancement

  • Technological innovation has completely changed the dynamics of the healthcare analytical testing services market. Improvement in proteomics, bioinformatics, and genomics has extended test speeds and accuracies. This is because better software and equipment deliver results more speedily and reliably, hence raising the demand for services of analytical testing. These developments have increased the application of these services, the analytical testing services, and subsequently have caused this market to grow. Further growth with continuous technological advancements is predicted and will make testing services even more effective and efficient.

Restraints

High Costs and Complexity

  • Two of the most influential barriers for this market are high pricing and complexity. Analytical testing services require complicated software, special equipment, and skilled labor; hence, such services are expensive. The complexity in testing and analysis could lead to errors and inconsistencies that may hamper the growth in the market. Due to these costs and complexity, it is hard for small and medium-scale industries to invest in analytical testing services. The limitation may weaken the growth in the market while companies weigh the benefits against the drawbacks.
  • Challenges from Regulations

Regulatory issues hamper the market, as analytical testing services must follow strict rules and regulations. This may impede the growth of the market since much time and finances are invested in the compliance processes. The uncertainty brought forward by changes within the regulation disrupts the market, along with the involvement of spending money on the analytical testing services by any business. Businesses work in accordance with these rules, which can make the entry of new players difficult. Regulatory hurdles are predicted to slow down market growth as businesses adapt to changing regulatory requirements.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Healthcare Analytical Testing Services Market size was valued at USD 7.39 Billion in 2023 and is poised to grow from USD 8.22 Billion in 2024 to USD 17.29 Billion by 2032, growing at a CAGR of 11.2% during the forecast period (2025-2032).

The market remains highly dynamic in nature, with almost incessant strategic moves by large firms in the form of alliances, mergers, acquisitions, and facility expansions. For instance, in April 2021, SGS SA completed its purchase of SYNLAB Analytics, a provider of pharmaceutical and food and environmental testing services. The purchase was targeted at expanding the analytical capacity of the company into areas of environmental, food, and pharmaceutical testing, having given access to SGS to over 37 new laboratories. 'Eurofins Scientific (Luxembourg) ', 'Laboratory Corporation of America Holdings (US) ', 'SGS S.A. (Switzerland) ', 'Charles River Laboratories (US) ', 'WuXi AppTec Co. Ltd. (China) ', 'Element Materials Technology (UK) ', 'Thermo Fisher Scientific, Inc. (US) ', 'Pace Analytical Services LLC (US) ', 'Intertek Group plc (UK) ', 'IQVIA Inc. (US) ', 'Merck KGaA (Germany) ', 'Source BioScience (UK) ', 'Almac Group (UK) ', 'ICON Plc (Ireland) ', 'Frontage Laboratories, Inc. (US) ', 'STERIS Plc (US) ', 'Sartorius AG (Germany) ', 'ALS Life Science (US) ', 'Syneos Health, INC (US) ', 'Medpace Holdings, Inc. (US)'

The increasing demand for medical testing services drives the market growth. Due to growing aging population and the higher prevalence of chronic conditions, the demand for diagnostic testing and its associated analytical services increased manifold. This has been driven by personalized medicine because it depends heavily on advanced testing and analysis. Increasing investment by health professionals and biopharmaceuticals in analytical testing services has given a lot of momentum to the market. As accurate and reliable diagnostic outcomes have become crucial, further expansion in the use of healthcare testing services is predicted to continue.

Outsourcing of Analytical Testing Services: Outsourcing of analytical testing services is gaining momentum in the healthcare analytical testing services market. Companies within the biotechnology and pharmaceutical industries are increasingly contracting specialist service providers to conduct their analytical testing work. The need to reduce costs, adopt advanced technologies, and focus on core competencies drives this trend. In this way, companies can boost productivity and improve turnaround times by outsourcing their analytical testing services through the resources and capabilities of specialist suppliers. Outsourcing was expected to gain greater popularity given the continuing rise in demand for analytical testing services.

North America held over 53.5% share of the global revenue share in 2023. The region is a host to advanced production hubs that design and produce complex, reliable, and superior quality products. High demand for testing services in healthcare and technical advancements drive the regional market. Favorable regulatory reforms and other transformations in the healthcare industry are predicted to pull biopharmaceutical firms to the U.S. market in conjunction with these factors. Developed infrastructure, expertise labor force, and broad scope for testing services in analysis will drive the business in ensuring the region's supremacy. North America will maintain its position in the global market as the healthcare industry keeps on evolving in many ways with developments.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Healthcare Analytical Testing Services Market
Healthcare Analytical Testing Services Market

Report ID: SQMIG35D2273

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE